Incyte Corp (NASDAQ:INCY) under-valued by 10%
| Website | https://www.incyte.com/ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $19,376,732,200 |
| Beta | 1.09227 |
| Average Volume | $1,137,767 |
| Last Dividend | 0% |
| Price on Aug 4, 2020 | $88.60 |
| Autochartist™ Valuation | $97.90 |
| Conclusion |
10% under-valued |
| Download Report |
